InChI=1S/C20H30O4/c1- 2- 3- 4- 5- 6- 9- 13- 18(21) 14- 10- 7- 8- 11- 15- 19(22) 16- 12- 17- 20(23) 24/h3- 4,6- 11,14- 15,18- 19,21- 22H,2,5,12- 13,16- 17H2,1H3,(H,23,24) /b4- 3- ,8- 7+,9- 6- ,14- 10+,15- 11- /t18- ,19- /m1/s1 |
BISQPGCQOHLHQK-HDNPQISLSA-N |
O[C@@H](CCCC(O)=O)\C=C/C=C/C=C/[C@H](O)C/C=C\C/C=C\CC |
|
Rattus norvegicus
(NCBI:txid10116)
|
See:
PubMed
|
Homo Sapiens
(NCBI:txid9606)
|
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
rat metabolite
Any mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
(5S,6Z,8E,10E,12R,14Z,17Z)- 5,12- dihydroxyicosa- 6,8,10,14,17- pentaenoic acid
|
(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-6,8,10,14,17-Eicosapentaenoic acid
|
HMDB
|
5,12-DiHEPE
|
HMDB
|
LTB5
|
HMDB
|
80445-66-5
|
CAS Registry Number
|
ChemIDplus
|
1320339
|
PubMed citation
|
Europe PMC
|
1335056
|
PubMed citation
|
Europe PMC
|
1647650
|
PubMed citation
|
Europe PMC
|
19685375
|
PubMed citation
|
Europe PMC
|
2160190
|
PubMed citation
|
Europe PMC
|
2167697
|
PubMed citation
|
Europe PMC
|
22959773
|
PubMed citation
|
Europe PMC
|
2437212
|
PubMed citation
|
Europe PMC
|
24507968
|
PubMed citation
|
Europe PMC
|
2563604
|
PubMed citation
|
Europe PMC
|
26771963
|
PubMed citation
|
Europe PMC
|
2836122
|
PubMed citation
|
Europe PMC
|
2852812
|
PubMed citation
|
Europe PMC
|
2983350
|
PubMed citation
|
Europe PMC
|
2996057
|
PubMed citation
|
Europe PMC
|
3025936
|
PubMed citation
|
Europe PMC
|
6091668
|
PubMed citation
|
Europe PMC
|
6318749
|
PubMed citation
|
Europe PMC
|
6321468
|
PubMed citation
|
Europe PMC
|
6326200
|
PubMed citation
|
Europe PMC
|
8415805
|
PubMed citation
|
Europe PMC
|
|